⌘K

Login Start Free

Home/Filings/4/0001104659-24-076893

4//SEC Filing

Hegde Priti 4

Accession 0001104659-24-076893

CIK 0001621227other

View on SEC.gov Company Profile

Filed

Jun 30, 8:00 PM ET

Accepted

Jul 1, 5:02 PM ET

Size

5.7 KB

Accession

0001104659-24-076893

Insider Transaction Report

Form 4

Period: 2024-07-01

Adaptimmune Therapeutics PLCADAP

Director

Transactions

Award
Option to purchase Ordinary Shares
2024-07-01+1,144,686→ 1,144,686 total
Exercise: $0.16From: 2025-07-01Exp: 2034-07-01→ Ordinary Shares (1,144,686 underlying)

Footnotes (1)

[F1]The exercise price was converted from GBP0.13 based on an exchange rate of $U.S. 1.263714 to GBP1.00. The actual exercise price will be the pounds sterling amount.

Documents

1 file

4
tm2418639-4_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Adaptimmune Therapeutics PLC

CIK 0001621227

Entity typeother

Related Parties

1

filerCIK 0001880034

Filing Metadata

Form type: 4
Filed: Jun 30, 8:00 PM ET
Accepted: Jul 1, 5:02 PM ET
Size: 5.7 KB

View on SEC.gov